North Star Investment Management’s Marker Therapeutics MRKR Stock Holding History

North Star Investment Management’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42	Closed	-$1K	–	1024
2020 Q2	$1K	Hold	42	–	–	﹤0.01%	944
2020 Q1	$1K	Hold	42	–	–	﹤0.01%	964
2019 Q4	$1K	Hold	42	–	–	﹤0.01%	1023
2019 Q3	$2K	Buy	+42	New	+$2.48K	﹤0.01%	1011
2019 Q2	–	Sell	-42	Closed	-$3K	–	716
2019 Q1	$3K	Hold	42	–	–	﹤0.01%	977
2018 Q4	$2K	Hold	42	–	–	﹤0.01%	987
2018 Q3	$4K	Hold	42	–	–	﹤0.01%	969
2018 Q2	$4K	Hold	42	–	–	﹤0.01%	982
2018 Q1	$1K	Hold	42	–	–	﹤0.01%	1046
2017 Q4	$2K	Sell	42 -181	-81%	-$5.56K	﹤0.01%	998
2017 Q3	$7K	Hold	223	–	–	﹤0.01%	892
2017 Q2	$9K	Hold	223	–	–	﹤0.01%	847
2017 Q1	$10K	Buy	+223	New	+$9.92K	﹤0.01%	802

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

North Star Investment Management's MRKR Position: Q3 2020 in Review

North Star Investment Management sold out of Marker Therapeutics (MRKR) in Q3 2020, closing a stake of 42 shares — an estimated $1K sold.

North Star Investment Management first reported a position in MRKR in Q1 2017 and held it in 13 quarters. The position peaked at $10K in Q1 2017. 58 funds tracked by Wall St. Rank hold MRKR as of Q3 2020.

North Star Investment Management reported no remaining Marker Therapeutics position as of Q3 2020 after selling out during the quarter.
North Star Investment Management sold 42 Marker Therapeutics shares in Q3 2020, an estimated $1K.
North Star Investment Management first reported a position in Marker Therapeutics in Q1 2017 and held it in 13 quarters.
North Star Investment Management's Marker Therapeutics position peaked at $10K in Q1 2017.
58 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2020.

Based on North Star Investment Management's 13F filing for Q3 2020, filed 13 Oct 2020.